Skip to main content
. 2020 Jan 1;2(1):vdaa005. doi: 10.1093/noajnl/vdaa005

Figure 4.

Figure 4.

Percentage of recovered 5-AZA in brain tissue concentrations per subject at 4 h post-intracisternal administration: (A) Subject 8 and (B) Subject 9. 5-AZA, 5-azacytidine.